Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
November 07 2017 - 4:05PM
Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company
focused on improving patients’ lives by identifying, developing,
acquiring and commercializing differentiated and accessible
medicines that address unmet medical needs, today announced that
the compensation committee of its board of directors approved the
grant on Nov. 6, 2017 of inducement restricted stock units for an
aggregate of 57,565 ordinary shares to 20 new employees.
Each restricted stock unit vests over four years, with 25
percent of the shares vesting on each anniversary of the applicable
vesting commencement date, subject to the new employee's continued
service relationship with the Company. Each restricted stock
unit also is subject to the terms and conditions of the Company's
2014 Equity Incentive Plan and the restricted stock unit agreement
pursuant to which the restricted stock unit was granted.
The restricted stock units were granted as inducements material
to the new employees entering into employment with Horizon Pharma
in accordance with NASDAQ Listing Rule 5635(c)(4).
About Horizon Pharma plcHorizon Pharma plc is a
biopharmaceutical company focused on improving patients' lives by
identifying, developing, acquiring and commercializing
differentiated and accessible medicines that address unmet medical
needs. The Company markets 11 medicines through its orphan,
rheumatology and primary care business units. For more
information, please visit www.horizonpharma.com. Follow @HZNPplc on
Twitter or view careers on our LinkedIn page.
Contacts:Tina VenturaSenior Vice President,
Investor RelationsInvestor-relations@horizonpharma.com
Ruth VenningExecutive Director, Investor
RelationsInvestor-relations@horizonpharma.com
U.S. Media Contact:Geoffrey CurtisSenior Vice President,
Corporate Affairs and Chief Communications
Officermedia@horizonpharma.com
Ireland Media Contact: Ray Gordon Gordon MRM
ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Sep 2023 to Sep 2024